Skip to main content

Table 1 Description of parameters regarding the detection of adverse events

From: Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols

  

National sponsors

International sponsors

 

Indicator

Observation

Yes (%)

Yes (%)

Total (%)

Persons assigned to detect adverse events

104

4 (3.8)

37 (35.6)

41 (39.4)

Defined a minor adverse event

104

4 (3.8)

53 (51.0)

57 (54.8)

Defined a serious adverse event

104

4 (3.8)

53 (51.0)

57 (54.8)

Indicated a time frame to detect adverse events

104

3 (2.9)

41 (39.4)

44 (42.3)

Described a Procedure for detecting adverse events

104

2 (1.9)

31 (29.8)

33 (31.7)

Case Report Form

96

4 (3.8)

35 (33.7)

39 (37.5)